Breast Testing at Inform Diagnostics
Comprehensive Breast Pathology Services
Inform Diagnostics offers a full range of testing for breast disease diagnosis
and management, including genomic testing services. Inform Diagnostics
believes in responsible test utilization and only orders tests that are
medically appropriate for accurate diagnosis.
Genetic testing is provided by
Baylor Genetics. Baylor has provided diagnostics services for more than 35 years and is
the number one National Institutes of Health-funded genetics program.
Learn more about Inform Diagnostics's
genomic testing services.
Breast Pathology Services at Inform Diagnostics
Our laboratory offers the following breast pathology services:
- TNM staging per CAP protocols
- Sentinel lymph node protocols (H&E, IHC)
- ER, PR, Ki67, HER2 predictive and prognostic testing
- HER2 CISH
- Metastasis confirmation
- Calcifications confirmation
- Flow cytometry on fresh tissue and body fluid
Genomic Testing Services
In addition to the pathology services listed above, we also facilitate
genomic testing services:
- BRCA1 and BRCA2 Screening, performed by Baylor Genetics
- High Risk Hereditary Breast Cancer Panel (7 genes: BRCA1, BRCA2, CDH1,
PALB2, PTEN, STK11, TP53), performed by Baylor Genetics
National Comprehensive Cancer Network (NCCN) Criteria for Genomic Testing
Guidelines from NCCN support testing for the BRCA1 and BRCA2 genes in patients
suspected of hereditary breast and/or ovarian cancer syndromes. Use Inform
NCCN Criteria form to help determine if your patient meets criteria in the NCCN Guidelines
for genetic risk evaluation of breast and/or ovarian cancer. Inform Diagnostics
often can use this information, in addition to clinical notes, for prior
“Women’s Center for Radiology uses Inform Diagnostics for
breast pathology. Our radiologist and staff have been pleased with the
service from the team at Inform Diagnostics. With its unique consensus
approach and commitment to research, we are more confident in the diagnoses
From years of performing breast biopsies, prior to using Inform Diagnostics,
we often questioned the lab, as the pathology did not match our suspicions.
With the partnership approach to our breast pathology, we are confident
that our clients are getting quality readings.
We recently engaged Inform Diagnostics to assist with Meaningful Use reporting
and other requirements. We are pleased with our responses from Inform
Diagnostics’s Technical Director, Client Service Advocates, Technical
Account Specialist and our Sales Director Steve Sharp. We look forward
to our continued working relationship.
In summary, we recommend Inform Diagnostics to any breast radiologist,
surgeon or oncologist. We are sure the experience you receive from Inform
Diagnostics will be exceptional.”
— Susan L. Curry, MD,
Founder and Medical Director, Women's Center for Radiology, Orlando, Fla.
Learn more about
insurance and billing for genomic testing